MPM Oncology Impact Management »

Alx Oncology Hldgs shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 2.2M 6.03
2024-03-31 $14M 1.3M 11.15

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Alx Oncology Hldgs

venBio Partners
Tang Capital Management
Redmile Group
BlackRock
BlackRock
MPM Oncology Impact Management
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Privium Fund Management B.V.
Acadian Asset Management
Cubist Systematic Strategies
Northern Trust
Kennedy Capital Management

View all funds holding Alx Oncology Hldgs